An Open Label, Randomized Study Prospectively Examining the Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin.

Trial Profile

An Open Label, Randomized Study Prospectively Examining the Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2017

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Anxiety
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Sep 2017 Status changed from completed to discontinued.
    • 24 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Oct 2013 Planned end date changed from 1 Jun 2012 to 1 Apr 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top